明晟公司MSCI北欧国家指数跌1.8%,报366.94点,创1月23日以来收盘新低。专门围绕癌症开发抗体疗法的生物技术公司Genmab A/S跌9.2%,领跌一众成分股。

金融界
12 Mar
明晟公司MSCI北欧国家指数跌1.8%,报366.94点,创1月23日以来收盘新低。专门围绕癌症开发抗体疗法的生物技术公司Genmab A/S跌9.2%,领跌一众成分股。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10